Login
Toggle sidebar

Lint: graves-ophthalmopathy

Strong List Colon Position
error

"T1: isointense to the other facial muscles, or fatty infiltration in the inactive phase"

Line 96:8 · When enboldening an intro, the colon should not be bold. '<strong>T1:</strong> isointense'

"T2/STIR: increased signal intensity may be seen due to the inflammatory process during the active phase, which normalises or becomes low signal during the inactive phase"

Line 97:8 · When enboldening an intro, the colon should not be bold. '<strong>T2/STIR: </strong>increased'

"T1 C+ (Gd): enhancement may be present in the active phase, not present in the inactive phase"

Line 98:8 · When enboldening an intro, the colon should not be bold. '<strong>T1 C+ (Gd): </strong>enhancement'
Headings Valid
warning

Expected headings

  • H1 Terminology
  • H1 Usage
  • H1 Epidemiology
  • H2 Risk factors
  • H2 Associations
  • H1 Clinical presentation
  • H2 Complications
  • H1 Diagnosis
  • H2 Diagnostic criteria
  • H2 Diagnostic clues
  • H1 Pathology
  • H2 Aetiology
  • H2 Location
  • H2 Classification
  • H2 Macroscopic appearance
  • H2 Microscopic appearance
  • H2 Immunophenotype
  • H2 Markers
  • H2 Genetics
  • H1 Radiographic features
  • H2 Plain radiograph
  • H2 Mammography
  • H2 Antenatal ultrasound
  • H2 Transoesophageal echocardiography
  • H2 Ultrasound
  • H2 CT
  • H3 Dual-energy CT
  • H2 Angiography (DSA)
  • H2 MRI
  • H2 CT/MRI
  • H2 Nuclear medicine
  • H3 PET-CT
  • H3 PET-MRI
  • H1 Radiology report
  • H1 Treatment and prognosis
  • H2 Complications
  • H1 History and etymology
  • H1 Differential diagnosis
  • H2 Clinical differential diagnosis
  • H1 Practical points
  • H1 See also

"Associations"

Line 43:1 · "Associations" is under the wrong parent heading (found under "Pathology").
Oxford Comma
suggestion

"proptosis/exophthalmos, with resultant periorbital oedema, chemosis and corneal dryness/ulceration"

Line 15:66 · Use the Oxford comma in 'oedema, chemosis and corneal'.
Commas
suggestion

"Although in many instances the disease activity plateaus in the inactive (stable or quiescent) phase 3,19, treatment is often required if there is diplopia, discomfort, any cosmetic issues, risk of corneal ulceration, and/or risk of optic nerve compression. Treatment during the initial active phase may reduce destructive sequela from inflammation 19."

Line 102:111 · More than 5 commas in a single sentence might make it more difficult to read.

"medical: supportive, selenium, glucocorticoids, rituximab, tocilizumab, teprotumumab, veligrotug"

Line 106:27 · More than 5 commas in a single sentence might make it more difficult to read.